{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:11:42Z","timestamp":1784265102838,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Coronary heart disease (CHD) is one of the leading causes of death worldwide. Percutaneous coronary intervention (PCI) has been an important technology for the treatment of CHD. Blood lipid management is critical for PCI patients because not only should local vascular pathological changes be considered but the whole atherosclerotic process should be considered as well.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 522 patients diagnosed with CHD (including acute myocardial infarction and unstable angina) successfully underwent stent implantation in acute or elective PCI in the cardiology department of one general hospital in Guangzhou from June 2015 to December 2017. The 2016 Chinese Guideline for the Management of dyslipidaemia in Adults and the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report (NCEP-ATP III) were used to classify total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 522 patients were recruited for the study. The mean values of TC, TG, LDL-C, and HDL-C at baseline were 4.76, 1.80, 2.93 and 1.03\u2009mmol\/L, respectively. After 1 year of follow-up, the mean values of TC, TG, LDL-C, and HDL-C were 3.94, 1.62, 2.26 and 1.01\u2009mmol\/L, respectively. The prevalence of high TC, high TG, high LDL-C and low HDL-C at baseline was 12.05, 21.80, 10.90 and 56.79%, respectively, and the prevalence at follow-up was 4.59, 15.68, 3.25 and 59.85%, respectively. Logistic regression revealed that gender was risk factor for high TC (\u2265 6.22\u2009mmol\/L), low HDL-C (&lt;\u20091.04\u2009mmol\/L) and high LDL-C (\u2265 4.14\u2009mmol\/L) at follow-up. Age was the factor associated with high TG (\u2265 2.26\u2009mmol\/L) and low HDL-C (&lt;\u20091.04\u2009mmol\/L) at follow-up. Besides, smoking and diet control were risk factors for low HDL-C (&lt;\u20091.04\u2009mmol\/L) and high LDL-C (\u2265 4.14\u2009mmol\/L) at follow-up, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The patients with PCI at follow-up experienced lower mean values of lipids and prevalence of dyslipidaemia than those at baseline. Gender, age, smoking and diet control were the risk factors associated with elevated lipids. Improvement in lipid management at follow up demonstrated that such intervention can be effective.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12944-020-01340-5","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T16:04:19Z","timestamp":1594051459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The analysis of the lipid levels in patients with coronary artery disease after percutaneous coronary intervention: a one-year follow-up observational study"],"prefix":"10.1186","volume":"19","author":[{"given":"Weiyu","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"key":"1340_CR1","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"GBD 2017 Causes of Death Collaborators","year":"2018","unstructured":"GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736\u201388.","journal-title":"Lancet"},{"key":"1340_CR2","doi-asserted-by":"publisher","first-page":"e013650","DOI":"10.1136\/bmjopen-2016-013650","volume":"7","author":"DR Collins","year":"2017","unstructured":"Collins DR, Tompson AC, Onakpoya U, Roberts N, Ward AM, Heneghan CJ. Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: systematic review of systematic review. BMJ Open. 2017;7:e013650.","journal-title":"BMJ Open"},{"key":"1340_CR3","unstructured":"American Heart Association: Cholesterol statistics. http:\/\/www.americanheart.org\/presenter.jhtml?identifier=536. Accessed 20 Oct 2016."},{"key":"1340_CR4","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1161\/CIRCRESAHA.107.151704","volume":"100","author":"Y Wen","year":"2007","unstructured":"Wen Y, Leake DS. Low density lipoprotein undergoes oxidation within lysosomes in cells. Circ Res. 2007;100:1337\u201343.","journal-title":"Circ Res"},{"key":"1340_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2337\/dc16-1958","volume":"40","author":"JS Lee","year":"2017","unstructured":"Lee JS, Chang PY, Zhang Y, Kizer JR, Best LG, Howard BV. Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic Dysregulation status: the strong heart study. Diabetes Care. 2017;40:529\u201337.","journal-title":"Diabetes Care"},{"key":"1340_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1161\/CIRCOUTCOMES.115.002436","volume":"9","author":"J Bartlett","year":"2016","unstructured":"Bartlett J, Predazzi IM, Williams SM, Bush WS, Kim Y, Havas S, Toth PP, Fazio S, Miller M. Is isolated low high-density lipoprotein cholesterol a cardiovascular disease risk factor? New insights from the Framingham offspring study. Circ Cardiovasc Qual Outcomes. 2016;9:206\u201312.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1340_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1161\/01.CIR.0000136583.52681.0D","volume":"110","author":"J He","year":"2004","unstructured":"He J, Gu D, Reynolds K, Wu X, Muntner P, Zhao J, Chen J, Liu D, Mo J, Whelton PK, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation. 2004;110:405\u201311.","journal-title":"Circulation."},{"key":"1340_CR8","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1161\/CIRCULATIONAHA.111.065904","volume":"125","author":"W Yang","year":"2012","unstructured":"Yang W, Xiao J, Yang Z, Ji L, Jia W, Weng J, Lu J, Shan Z, Liu J, Tian H, et al. Serum lipids and lipoproteins in Chinese men and women. Circulation. 2012;125:2212\u201321.","journal-title":"Circulation."},{"key":"1340_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","volume":"380","author":"B Mihaylova","year":"2012","unstructured":"Cholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, et al. The effects of lowering LDL-C cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581\u201390.","journal-title":"Lancet"},{"key":"1340_CR10","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.5114\/amsad.2017.70596","volume":"2","author":"MA Harris","year":"2017","unstructured":"Harris MA, Ferguson TS, Boyne MS, Figueroa JP. High prevalence of dyslipidemia among primary care patients with hypertension and diabetes in Jamaica. Arch Med Sci Atheroscler Dis. 2017;2:e61\u20137.","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"1340_CR11","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s12325-019-00941-6","volume":"36","author":"F Spannella","year":"2019","unstructured":"Spannella F, Giulietti F, Di Pentima C, Sarzani R. Prevalence and control of dyslipidemia in patients referred for high blood pressure: the disregarded \u201cdouble-trouble\u201d lipid profile in overweight\/obese. Adv Ther. 2019;36:1426\u201337.","journal-title":"Adv Ther"},{"key":"1340_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijcard.2017.12.069","volume":"260","author":"M Zhang","year":"2018","unstructured":"Zhang M, Deng Q, Wang L, Huang Z, Zhou M, Li Y, Zhao Z, Zhang Y, Wang L. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults. Int J Cardiol. 2018;260:196\u2013203.","journal-title":"Int J Cardiol"},{"key":"1340_CR13","first-page":"118","volume":"12","author":"YH Li","year":"2002","unstructured":"Li YH, Li Y, Davis CE, Chen Z, Tao S, Folsom AR, Bachorik P, Stamler J, Abernathy JR. Serum cholesterol changes from 1983-1984 to 1993-1994 in the People\u2019s republic of China. Nutr Metab Cardiovasc Dis. 2002;12:118\u201326.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1340_CR14","first-page":"474","volume":"26","author":"LM Li","year":"2005","unstructured":"Li LM, Rao KQ, Kong LZ, Yao CH, Xiang HD, Zhai FY, Ma GS, Yang XG. Chinese resident nutrition and health survey technology executive team. The 2002 China National Nutrition and health survey. Chin J Epidemiol. 2005;26:474\u201384 (in Chinese).","journal-title":"Chin J Epidemiol"},{"key":"1340_CR15","first-page":"833","volume":"44","author":"Joint Committee Issued Chinese Guideline for the Management of Dyslipidemia in Adults","year":"2016","unstructured":"Joint Committee Issued Chinese Guideline for the Management of Dyslipidemia in Adults. Chinese guideline for the management of dyslipidemia in adults. Chinese J Cardiol. 2016;44:833\u201353 in Chinese.","journal-title":"Chinese J Cardiol"},{"key":"1340_CR16","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2011","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2011;285:2486\u201397.","journal-title":"JAMA."},{"key":"1340_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539\u201353.","journal-title":"Diabet Med"},{"key":"1340_CR18","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S0140-6736(12)61085-X","volume":"380","author":"GA Giovino","year":"2012","unstructured":"Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, Peto R, Zatonski W, Hsia J, Morton J, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet. 2012;380:668\u201379.","journal-title":"Lancet."},{"key":"1340_CR19","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/jama.2012.13260","volume":"308","author":"MD Carroll","year":"2012","unstructured":"Carroll MD, Kit BK, Lacher DA, Shero ST, Mussolino ME. Trends in lipids and lipoproteins in US adults, 1988-2010. JAMA. 2012;308:1545\u201354.","journal-title":"JAMA."},{"key":"1340_CR20","doi-asserted-by":"crossref","unstructured":"Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, et al. Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb 2006;13:202\u2013208.","DOI":"10.5551\/jat.13.202"},{"key":"1340_CR21","doi-asserted-by":"crossref","first-page":"e000650","DOI":"10.1161\/JAHA.113.000650","volume":"3","author":"YH Lee","year":"2014","unstructured":"Lee YH, Lee SG, Lee MH, Kim JH, Lee BW, Kang ES, Lee HC, Cha BS. Serum cholesterol concentration and prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in the Korea National Health and nutrition examination surveys 2008\u20132010: beyond the tip of the iceberg. J Am Heart Assoc. 2014;3:e000650.","journal-title":"J Am Heart Assoc"},{"key":"1340_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12944-018-0768-7","volume":"17","author":"X Liu","year":"2018","unstructured":"Liu X, Yu S, Mao Z, Li Y, Zhang H, Yang K, Zhang H, Liu R, Qian X, Li L, et al. Dyslipidemia prevalence, awareness, treatment, control and risk factors in Chinese rural population: the Henan rural cohort study. Lipids Health Dis. 2018;17:119.","journal-title":"Lipids Health Dis"},{"key":"1340_CR23","doi-asserted-by":"crossref","unstructured":"Yuan X, Ni W, Wang R, Chi H, Sun Y, Lv D, Liu P, Xu J. 6-year trends in lipids among adults in Shenzhen, China. J Public Health (Oxf). 2019; pii: fdz113.","DOI":"10.1093\/pubmed\/fdz113"},{"key":"1340_CR24","doi-asserted-by":"publisher","first-page":"184945441877931","DOI":"10.1177\/1849454418779310","volume":"7","author":"RB Jain","year":"2018","unstructured":"Jain RB, Ducatman A. Association between smoking and lipid\/lipoprotein concentrations among US adults aged \u226520 years. J Circ Biomark. 2018;7:1849454418779310.","journal-title":"J Circ Biomark"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-01340-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-020-01340-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-01340-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T11:58:14Z","timestamp":1667303894000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-020-01340-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1186\/s12944-020-01340-5","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"26 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the first affiliated hospital of Jinan University Ethics Committee (Ethical Approval Number: 20190812\u2013033; Approval date: 12th, August 2019.).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}